Published in Semin Immunopathol on October 07, 2014
Activating KIRs and NKG2C in Viral Infections: Toward NK Cell Memory? Front Immunol (2015) 0.83
Global Mapping of O-Glycosylation of Varicella Zoster Virus, Human Cytomegalovirus, and Epstein-Barr Virus. J Biol Chem (2016) 0.76
Cytomegalovirus-Infected Cells Resist T Cell Mediated Killing in an HLA-Recognition Independent Manner. Front Microbiol (2016) 0.75
Highly individual patterns of virus-immune IgG effector responses in humans. Med Microbiol Immunol (2016) 0.75
Characterization of Antibody Bipolar Bridging Mediated by the Human Cytomegalovirus Fc Receptor gp68. J Virol (2016) 0.75
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus. PLoS Pathog (2017) 0.75
Telomere Shortening, Inflammatory Cytokines, and Anti-Cytomegalovirus Antibody Follow Distinct Age-Associated Trajectories in Humans. Front Immunol (2017) 0.75
Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr Top Microbiol Immunol (1990) 16.31
Fcgamma receptors as regulators of immune responses. Nat Rev Immunol (2008) 11.34
IgG Fc receptors. Annu Rev Immunol (2001) 8.63
FcRn: the neonatal Fc receptor comes of age. Nat Rev Immunol (2007) 7.94
Fc receptors. Annu Rev Immunol (1991) 7.92
Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol (1996) 6.64
Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice. Nature (1996) 5.25
Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. J Biol Chem (2002) 5.10
Antibodies, viruses and vaccines. Nat Rev Immunol (2002) 4.92
CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. J Virol (1987) 4.58
A novel di-leucine motif and a tyrosine-based motif independently mediate lysosomal targeting and endocytosis of CD3 chains. Cell (1992) 4.39
Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc Natl Acad Sci U S A (2003) 4.37
Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. J Virol (2004) 4.30
Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood (2008) 4.10
A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus. N Engl J Med (2014) 3.92
Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect Dis (2004) 3.78
Genetic content of wild-type human cytomegalovirus. J Gen Virol (2004) 3.58
The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex. Nature (2000) 3.53
The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genome. J Gen Virol (2003) 3.48
Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood (2004) 3.36
Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus. Science (2010) 3.31
The antiviral activity of antibodies in vitro and in vivo. Adv Immunol (2001) 3.29
Protein A of Staphylococcus aureus and related immunoglobulin receptors produced by streptococci and pneumonococci. Adv Immunol (1982) 3.28
The IgG receptor induced by herpes simplex virus: studies using radioiodinated IgG. J Gen Virol (1974) 3.17
Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D. Nat Immunol (2008) 3.14
ADSORPTION OF SENSITIZED SHEEP ERYTHROCYTES TO HELA CELLS INFECTED WITH HERPES SIMPLEX VIRUS. Nature (1964) 2.78
Broadly neutralizing antiviral antibodies. Annu Rev Immunol (2013) 2.77
Immune evasion by cytomegalovirus--survival strategies of a highly adapted opportunist. Trends Microbiol (1998) 2.75
Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J Exp Med (1998) 2.60
Properties of mouse and human IgG receptors and their contribution to disease models. Blood (2012) 2.53
Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. Trends Microbiol (2002) 2.48
High incidence of active cytomegalovirus infection among septic patients. Clin Infect Dis (1998) 2.48
Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood (2005) 2.40
Fc-receptors as regulators of immunity. Adv Immunol (2007) 2.38
The structure of a human type III Fcgamma receptor in complex with Fc. J Biol Chem (2001) 2.33
Human cytomegalovirus escapes a naturally occurring neutralizing antibody by incorporating it into assembling virions. Cell Host Microbe (2011) 2.20
Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J Exp Med (1994) 2.17
A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G. J Virol (1989) 2.08
Crystal structure of the HSV-1 Fc receptor bound to Fc reveals a mechanism for antibody bipolar bridging. PLoS Biol (2006) 1.99
Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1. Nat Med (2012) 1.93
Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs. J Virol (2002) 1.92
Human antibody-Fc receptor interactions illuminated by crystal structures. Nat Rev Immunol (2004) 1.91
Structural recognition and functional activation of FcgammaR by innate pentraxins. Nature (2008) 1.88
Two novel spliced genes in human cytomegalovirus. J Gen Virol (2003) 1.87
Antibody-mediated modulation of immune responses. Immunol Rev (2010) 1.84
HCMV gH/gL/UL128-131 interferes with virus entry into epithelial cells: evidence for cell type-specific receptors. Proc Natl Acad Sci U S A (2008) 1.79
Virus-specific antibody activity of different subclasses of immunoglobulins G and A in cytomegalovirus infections. Infect Immun (1983) 1.78
Immune escape and exploitation strategies of cytomegaloviruses: impact on and imitation of the major histocompatibility system. Cell Microbiol (2004) 1.76
The function of Fcγ receptors in dendritic cells and macrophages. Nat Rev Immunol (2014) 1.75
Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro. Blood (2007) 1.73
Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity. J Virol (1991) 1.73
Cytomegalovirus and brain tumor: epidemiology, biology and therapeutic aspects. Curr Opin Oncol (2013) 1.69
Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond. Nat Rev Drug Discov (2012) 1.62
In vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobulin G Fc receptor. J Virol (1998) 1.59
Fucose depletion from human IgG1 oligosaccharide enhances binding enthalpy and association rate between IgG1 and FcgammaRIIIa. J Mol Biol (2004) 1.59
Type I and type II Fc receptors regulate innate and adaptive immunity. Nat Immunol (2014) 1.58
Immunoglobulin prophylaxis in hematopoietic stem cell transplantation: systematic review and meta-analysis. J Clin Oncol (2008) 1.52
FcγRs in health and disease. Curr Top Microbiol Immunol (2011) 1.51
Sequential mutations associated with adaptation of human cytomegalovirus to growth in cell culture. J Gen Virol (2010) 1.51
Immune evasion of natural killer cells by viruses. Curr Opin Immunol (2008) 1.51
Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replication. J Clin Invest (2010) 1.50
Inhibition of immune responses by ITAM-bearing receptors. Sci STKE (2006) 1.50
Hemadsorption by herpes simplex-infected cell cultures. Int Arch Allergy Appl Immunol (1968) 1.48
Cytomegalovirus reinfections in healthy seroimmune women. J Infect Dis (2010) 1.46
Virus attenuation after deletion of the cytomegalovirus Fc receptor gene is not due to antibody control. J Virol (1998) 1.44
Inhibitory pathways triggered by ITIM-containing receptors. Adv Immunol (1999) 1.44
Interference with antigen processing by viruses. Curr Opin Immunol (1997) 1.40
IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides. J Immunol Methods (2005) 1.37
Impact of immune complex size and glycosylation on IgG binding to human FcγRs. J Immunol (2013) 1.36
Enhanced neonatal Fc receptor function improves protection against primate SHIV infection. Nature (2014) 1.35
Cutting edge: antibody-dependent memory-like NK cells distinguished by FcRγ deficiency. J Immunol (2013) 1.35
The interplay between host and viral factors in shaping the outcome of cytomegalovirus infection. Immunol Cell Biol (2006) 1.34
FcRn: the MHC class I-related receptor that is more than an IgG transporter. Immunol Today (1997) 1.30
The impact of CMV infection on survival in older humans. Curr Opin Immunol (2012) 1.28
The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. J Exp Med (2006) 1.27
Enhanced natural killer cell binding and activation by low-fucose IgG1 antibody results in potent antibody-dependent cellular cytotoxicity induction at lower antigen density. Clin Cancer Res (2005) 1.25
Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor. J Virol (1994) 1.24
Pentraxins: structure, function, and role in inflammation. ISRN Inflamm (2013) 1.23
Sequences of complementary DNAs that encode the NA1 and NA2 forms of Fc receptor III on human neutrophils. J Clin Invest (1989) 1.22
Phenotypic variation in IgG receptors by nonclassical FCGR2C alleles. J Immunol (2011) 1.16
Human cytomegalovirus open reading frame TRL11/IRL11 encodes an immunoglobulin G Fc-binding protein. J Virol (2001) 1.15
Rhesus CMV: an emerging animal model for human CMV. Med Microbiol Immunol (2008) 1.14
The humoral immune response against human cytomegalovirus is characterized by a delayed synthesis of glycoprotein-specific antibodies. J Infect Dis (1997) 1.13
Fc gamma RIIa, not Fc gamma RIIb, is constitutively and functionally expressed on skin-derived human mast cells. J Immunol (2006) 1.13
Monoclonal antibodies capable of discriminating the human inhibitory Fcgamma-receptor IIB (CD32B) from the activating Fcgamma-receptor IIA (CD32A): biochemical, biological and functional characterization. Immunology (2007) 1.10
Regulation of the steady state level of Fc gamma RI mRNA by IFN-gamma and dexamethasone in human monocytes, neutrophils, and U-937 cells. J Immunol (1990) 1.10
Identification of human NK cells that are deficient for signaling adaptor FcRγ and specialized for antibody-dependent immune functions. Int Immunol (2012) 1.08
Protection from CMV infection in immunodeficient hosts by adoptive transfer of memory B cells. Blood (2007) 1.06
The immunologic functions of the neonatal Fc receptor for IgG. J Clin Immunol (2012) 1.06
Fcγ receptors inhibit mouse and human basophil activation. J Immunol (2012) 1.06
TGF-beta 1 suppresses [correction of supresses] myeloid Fc gamma receptor function by regulating the expression and function of the common gamma-subunit. J Immunol (2003) 1.05
Viral interference with B7-1 costimulation: a new role for murine cytomegalovirus fc receptor-1. J Immunol (2006) 1.04
Three genes for the human high affinity Fc receptor for IgG (Fc gamma RI) encode four distinct transcription products. J Biol Chem (1992) 1.04
Human basophils express the glycosylphosphatidylinositol-anchored low-affinity IgG receptor FcgammaRIIIB (CD16B). J Immunol (2009) 1.03
Chimeric Fc receptors identify functional domains of the murine high affinity receptor for IgG. J Immunol (1991) 1.02
Fcγ receptor antigen targeting potentiates cross-presentation by human blood and lymphoid tissue BDCA-3+ dendritic cells. Blood (2012) 1.01
The human low affinity immunoglobulin G Fc receptor IIC gene is a result of an unequal crossover event. J Biol Chem (1993) 1.01
Human cytomegalovirus Fcγ binding proteins gp34 and gp68 antagonize Fcγ receptors I, II and III. PLoS Pathog (2014) 1.00
Immunoregulatory roles for fc receptor-like molecules. Curr Top Microbiol Immunol (2011) 0.99
Human cytomegalovirus-induced NKG2C(hi) CD57(hi) natural killer cells are effectors dependent on humoral antiviral immunity. J Virol (2013) 0.98
Host immune system gene targeting by a viral miRNA. Science (2007) 5.10
Memory inflation: continuous accumulation of antiviral CD8+ T cells over time. J Immunol (2003) 3.02
Decoding human cytomegalovirus. Science (2012) 2.98
MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo. Nat Immunol (2002) 2.66
Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus. Nat Immunol (2011) 2.51
Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood (2005) 2.40
Cloning and sequencing of a highly productive, endotheliotropic virus strain derived from human cytomegalovirus TB40/E. J Gen Virol (2008) 2.35
A novel human polyomavirus closely related to the african green monkey-derived lymphotropic polyomavirus. J Virol (2011) 2.03
Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs. J Virol (2002) 1.92
A cytomegaloviral protein reveals a dual role for STAT2 in IFN-{gamma} signaling and antiviral responses. J Exp Med (2005) 1.68
Case definition for progressive multifocal leukoencephalopathy following treatment with monoclonal antibodies. J Neurol Neurosurg Psychiatry (2012) 1.66
Early clinical experiences with the new influenza A (H1N1/09). Dtsch Arztebl Int (2009) 1.65
NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. J Exp Med (2005) 1.60
Hepatitis C virus mutation affects proteasomal epitope processing. J Clin Invest (2004) 1.58
Expansion of protective CD8+ T-cell responses driven by recombinant cytomegaloviruses. J Virol (2004) 1.55
NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies. Blood (2010) 1.38
The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. J Exp Med (2006) 1.27
Rapid replacement of endemic measles virus genotypes. J Gen Virol (2002) 1.25
Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein. J Virol (2005) 1.21
Human cytomegalovirus interferes with signal transducer and activator of transcription (STAT) 2 protein stability and tyrosine phosphorylation. J Gen Virol (2008) 1.19
The cytomegaloviral protein pUL138 acts as potentiator of tumor necrosis factor (TNF) receptor 1 surface density to enhance ULb'-encoded modulation of TNF-α signaling. J Virol (2011) 1.17
IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion. J Clin Invest (2014) 1.17
Construction of a fully retargeted herpes simplex virus 1 recombinant capable of entering cells solely via human epidermal growth factor receptor 2. J Virol (2008) 1.16
Laboratory investigations are indispensable to monitor the progress of measles elimination--results of the German Measles Sentinel 1999-2003. J Clin Virol (2004) 1.11
Modulation of NKp30- and NKp46-mediated natural killer cell responses by poxviral hemagglutinin. PLoS Pathog (2011) 1.11
Probing neutralizing-antibody responses against emerging measles viruses (MVs): immune selection of MV by H protein-specific antibodies? J Gen Virol (2005) 1.06
The dynamics of mouse cytomegalovirus-specific CD4 T cell responses during acute and latent infection. J Immunol (2008) 1.03
Absence of cross-presenting cells in the salivary gland and viral immune evasion confine cytomegalovirus immune control to effector CD4 T cells. PLoS Pathog (2011) 1.00
A cytomegalovirus inhibitor of gamma interferon signaling controls immunoproteasome induction. J Virol (2004) 0.99
CD34+ progenitor cells mobilized by natalizumab are not a relevant reservoir for JC virus. Mult Scler (2010) 0.98
Nonstructural 3/4A protease of hepatitis C virus activates epithelial growth factor-induced signal transduction by cleavage of the T-cell protein tyrosine phosphatase. Hepatology (2009) 0.95
c-Src is required for complex formation between the hepatitis C virus-encoded proteins NS5A and NS5B: a prerequisite for replication. Hepatology (2011) 0.94
"Activated" STAT proteins: a paradoxical consequence of inhibited JAK-STAT signaling in cytomegalovirus-infected cells. J Immunol (2013) 0.92
Vaccination against infection in patients with multiple sclerosis. Nat Rev Neurol (2012) 0.91
Identification of DNA-damage DNA-binding protein 1 as a conditional essential factor for cytomegalovirus replication in interferon-γ-stimulated cells. PLoS Pathog (2011) 0.90
The human cytomegalovirus Fc receptor gp68 binds the Fc CH2-CH3 interface of immunoglobulin G. J Virol (2008) 0.90
Gamma interferon-induced interferon regulatory factor 1-dependent antiviral response inhibits vaccinia virus replication in mouse but not human fibroblasts. J Virol (2009) 0.90
Classical and non-classical MHC I molecule manipulation by human cytomegalovirus: so many targets—but how many arrows in the quiver? Cell Mol Immunol (2014) 0.90
Inhibition of mouse TAP by immune evasion molecules encoded by non-murine herpesviruses. Mol Immunol (2011) 0.89
The role of multiplex PCR in respiratory tract infections in children. Dtsch Arztebl Int (2014) 0.87
The crucial role of molecular diagnostics. Dtsch Arztebl Int (2014) 0.87
Physical and functional interactions of the cytomegalovirus US6 glycoprotein with the transporter associated with antigen processing. J Biol Chem (2005) 0.87
Human cytomegalovirus disrupts the major histocompatibility complex class I peptide-loading complex and inhibits tapasin gene transcription. J Virol (2011) 0.86
Mouse cytomegalovirus inhibits beta interferon (IFN-beta) gene expression and controls activation pathways of the IFN-beta enhanceosome. J Gen Virol (2008) 0.86
Outcome of parent-physician communication skills training for pediatric residents. Patient Educ Couns (2010) 0.86
Cell contact-dependent priming and Fc interaction with CD32+ immune cells contribute to the TGN1412-triggered cytokine response. J Immunol (2014) 0.85
Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody. Proc Natl Acad Sci U S A (2013) 0.85
Herpesviral Fcgamma receptors: culprits attenuating antiviral IgG? Int Immunopharmacol (2004) 0.84
[Communication training using "standardized parents" for paediatricians--structured competence-based training within the scope of continuing medical education]. Z Arztl Fortbild Qualitatssich (2007) 0.83
[Final-year medical students as tutors for undergraduate students during their on-ward courses in internal medicine: a quantitative analysis]. Z Evid Fortbild Qual Gesundhwes (2008) 0.83
The human cytomegalovirus-specific UL1 gene encodes a late-phase glycoprotein incorporated in the virion envelope. J Virol (2012) 0.82
The human cytomegalovirus glycoprotein UL16 traffics through the plasma membrane and the nuclear envelope. Cell Microbiol (2006) 0.82
Lymphangiogenesis occurs in upper tract urothelial carcinoma and correlates with lymphatic tumour dissemination and poor prognosis. BJU Int (2008) 0.81
HCMV glycoprotein US6 mediated inhibition of TAP does not affect HLA-E dependent protection of K-562 cells from NK cell lysis. Hum Immunol (2003) 0.80
A natural tapasin isoform lacking exon 3 modifies peptide loading complex function. Eur J Immunol (2013) 0.80
A novel assay for detecting virus-specific antibodies triggering activation of Fcγ receptors. J Immunol Methods (2012) 0.79
Cytomegalovirus immune evasion of myeloid lineage cells. Med Microbiol Immunol (2015) 0.78
Checks and balances between human cytomegalovirus replication and indoleamine-2,3-dioxygenase. J Gen Virol (2013) 0.77
High genotypic diversity and a novel variant of human cytomegalovirus revealed by combined UL33/UL55 genotyping with broad-range PCR. Virol J (2009) 0.77
Exploitation of herpesviral transactivation allows quantitative reporter gene-based assessment of virus entry and neutralization. PLoS One (2011) 0.77
Genetic analysis and antigenic characterization of human respiratory syncytial virus group A viruses isolated in Germany 1996-2008. Virus Genes (2013) 0.76
[University medical education in transition]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2009) 0.76
Interplay between CMVs and interferon signaling: implications for pathogenesis and therapeutic intervention. Future Microbiol (2012) 0.76
Noncontrolled trial of monovalent AS03A-adjuvanted vaccine for 2009 pandemic influenza A(H1N1) in long-term dialysis patients and transplant recipients. Am J Kidney Dis (2011) 0.75
Intuition beyond recognition: when less familiar events are liked more. Exp Psychol (2003) 0.75
RAIDD Mediates TLR3 and IRF7 Driven Type I Interferon Production. Cell Physiol Biochem (2016) 0.75